The healthcare supply chain in Japan, as in all major markets, consists of biopharmaceutical manufacturers selling to wholesalers who in turn sell to hospitals, clinics, and pharmacies, where the drugs are finally dispensed to patients. Each party ideally contributes value…
HOME > COLUMN
COLUMN
- Maurer's Healthcare Insight (114)
October 26, 2009
- Maurer's Healthcare Insight (113)
October 5, 2009
- Maurer's Healthcare Insight (112)
September 14, 2009
- Maurer's Healthcare Insight (111)
August 24, 2009
- Maurer's Healthcare Insight (110)
July 27, 2009
- Maurer's Healthcare Insight (109)
June 22, 2009
- Maurer's Healthcare Insight (108)
May 18, 2009
- Maurer's Healthcare Insight (107)
April 27, 2009
- Maurer's Healthcare Insight (106)
March 30, 2009
- Maurer's Healthcare Insight (105)
March 2, 2009
- Maurer's Healthcare Insight (104)
January 26, 2009
- Maurer's Healthcare Insight (103)
January 5, 2009
- Maurer's Healthcare Insight (102)
December 8, 2008
- Maurer's Healthcare Insight (101)
December 1, 2008
- Maurer's Healthcare Insight (100)
October 27, 2008
- Maurer's Healthcare Insight (99)
September 29, 2008
- Maurer's Healthcare Insight (98)
August 25, 2008
- Maurer's Healthcare Insight (97)
July 28, 2008
- Maurer's Healthcare Insight (96)
June 23, 2008
- Maurer's Healthcare Insight (95)
May 19, 2008
ページ
“Balance” seems to be the keyword for the next drug pricing reform in FY2024. Japan now appears ready to seek a better balance between evaluating innovative medicines and taking tough measures against companies dependent on long-listed products (LLPs) and generic…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…